<DOC>
	<DOC>NCT00829907</DOC>
	<brief_summary>The purpose of the study is to evaluate the effect of ORM-12741 on receptor occupancy by positron emission tomography with different doses and plasma concentrations. The pharmacokinetic profile and safety will also be evaluated.</brief_summary>
	<brief_title>A PET Study With ORM-12741</brief_title>
	<detailed_description />
	<criteria>Good general health ascertained by detailed medical history and physical examination Males between 18 and 45 years Body mass index (BMI; weight/height2) between 1830 kg/m2 Weight 5595 kg Evidence of clinically significant cardiovascular, renal, hepatic, haematological, gastrointestinal, pulmonary, metabolicendocrine, neurological, urogenital or psychiatric disease as judged by the investigator Any condition requiring regular concomitant medication including herbal products or likely to need any concomitant medication during the study Regular consumption of more than 21 units of alcohol per week (1 unit = 4 cl spirits, about 13 g of alcohol). Current use of nicotinecontaining products more than 5 cigarettes or equivalent/day Inability to refrain from using nicotinecontaining products during the stay at the study centre Inability to refrain from consuming caffeinecontaining beverages during the stay at the study centre e.g. propensity for headache when refraining from caffeinecontaining beverages Blood donation or loss of significant amount of blood within 3 months prior to the screening visit Abnormal 12lead electrocardiogram (ECG) finding of clinical relevance Any abnormal value of laboratory, vital signs, or physical examination, which may in the opinion of the investigator interfere with the interpretation of the test results or cause a health risk for the subject if he takes part into the study Anatomical abnormality in brain MRI which may in the opinion of the investigator interfere with the interpretation of the PET results Participation in another clinical drug study within 3 months prior to the start of this study or earlier participation in a clinical study with ORM12741 Participation in a prior PET study Any contraindication to MRI of the brain</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Healthy volunteer study</keyword>
</DOC>